Nova Patents
AT538765T

A buprenorphine transdermal patch for use in the treatment of pain for a dosing interval of at least 7 days

Abstract

This record has no abstract on file.

Term

Term ended

Expired 24 February 2018, 8.6 years ago.

  1. Priority
  2. Filed
  3. Granted
  4. Expired
  5. Today

125 members in 22 offices

This recordMember, by publication datePriority claim12 more offices are in the list below

Priority claims2

Priority claims
DocumentOfficeKindDate
3891997United States of AmericaP
93906897United States of AmericaA

Members125

Family members, oldest first
DocumentOfficeKind
CA2276170A1CanadaA1
WO9836728A2World Intellectual Property Organization (WIPO)A2
AU6184198AAustraliaA
WO9836728A3World Intellectual Property Organization (WIPO)A3
NO994087D0NorwayD0
US5968547AUnited States of AmericaA
NO20064395LNorwayL
NO20074292LNorwayL
NO20101190LNorwayL
NO20111441LNorwayL
NO20120563LNorwayL
NO20130298LNorwayL
NO20131533LNorwayL
NO20151450A1NorwayA1
NO994087LNorwayL
EP0964677A1European Patent Office (EPO)A1
CZ300999A3CzechiaA3
PL335306A1PolandA1
CN1252705AChinaA
JP2000511936AJapanA
KR20000075648ARepublic of KoreaA
HU0002342A2HungaryA2
HU1200599A2HungaryA2
HUP0002342A2HungaryA2
HUP1200599A2HungaryA2
HUP1500370D0HungaryD0
IL131561D0IsraelD0
HU0002342A3HungaryA3
HUP0002342A3HungaryA3
US6231886B1United States of AmericaB1
US2001002259A1United States of AmericaA1
NZ337386ANew ZealandA
BR9815439ABrazilA
AU743071B2AustraliaB2
US6344212B2United States of AmericaB2
AU2925402AAustraliaA
EP0964677A4European Patent Office (EPO)A4
US2003091631A1United States of AmericaA1
US2003198675A1United States of AmericaA1
AU774779B2AustraliaB2
AU2004218685A1AustraliaA1
EP1570823A2European Patent Office (EPO)A2
EP1570823A3European Patent Office (EPO)A3
EP0964677B1European Patent Office (EPO)B1
CN1827107AChinaA
AT336212TAustriaT
ATE336212T1AustriaT1
DE69835584D1GermanyD1
US2006216340A1United States of AmericaA1
NO322515B1NorwayB1
DK0964677T3DenmarkT3
EP1731152A2European Patent Office (EPO)A2
PT964677EPortugalE
SI0964677T1SloveniaT1
KR100703101B1Republic of KoreaB1
ES2271988T3SpainT3
HK1096847A1Hong Kong, ChinaA1
DE69835584T2GermanyT2
DE05011213T1GermanyT1
EP1731152A3European Patent Office (EPO)A3
CA2276170CCanadaC
HK1103621A1Hong Kong, ChinaA1
PL196086B1PolandB1
CZ299414B6CzechiaB6
AU2008261134A1AustraliaA1
AU2004218685B2AustraliaB2
CN1827107BChinaB
IL131561AIsraelA
USRE41408EUnited States of AmericaE
USRE41489EUnited States of AmericaE
USRE41571EUnited States of AmericaE
NO329734B1NorwayB1
IL201437AIsraelA
NO329838B1NorwayB1
EP2301493A1European Patent Office (EPO)A1
EP2301494A1European Patent Office (EPO)A1
EP2305191A1European Patent Office (EPO)A1
EP2305192A1European Patent Office (EPO)A1
EP2305193A1European Patent Office (EPO)A1
EP2305194A1European Patent Office (EPO)A1
IL214299D0IsraelD0
US2011288112A1United States of AmericaA1
EP1570823B1European Patent Office (EPO)B1
IL207067AIsraelA
AT538765TThis recordAustriaT
ATE538765T1AustriaT1
DK1570823T3DenmarkT3
PT1570823EPortugalE
HK1153377A1Hong Kong, ChinaA1
SI1570823T1SloveniaT1
ES2380023T3SpainT3
EP2305194B1European Patent Office (EPO)B1
AT556682TAustriaT
ATE556682T1AustriaT1
AU2008261134B2AustraliaB2
NO332248B1NorwayB1
DK2305194T3DenmarkT3
PT2305194EPortugalE
ES2387752T3SpainT3
SI2305194T1SloveniaT1
Showing 100 of 125